Suppr超能文献

基于G蛋白偶联受体相关基因探索肾透明细胞癌的癌基因

Exploring oncogenes for renal clear cell carcinoma based on G protein-coupled receptor-associated genes.

作者信息

Zhu Chengcun, Sun Zhou, Wang Jie, Meng Xiangdi, Ma Zhaosen, Guo Rui, Niu Jiqiang, Tran Lisa Jia, Zhang Jing, Jiang Tianxiao, Liu Yunfei, Ye Fangdie, Ma Baoluo

机构信息

Department of Urology, The First People's Hospital of Jiangxia District, Wuhan, 430200, Hubei, China.

Department of Urology, China-Japan Union Hospital of Jilin University, Changchun, 130000, Jilin, China.

出版信息

Discov Oncol. 2023 Oct 10;14(1):182. doi: 10.1007/s12672-023-00795-z.

Abstract

G protein-coupled receptors (GPCRs) are a class of receptors on cell membranes that regulate various biological processes in cells, such as cell proliferation, differentiation, migration, apoptosis, and metabolism, by interacting with G proteins. However, the role of G protein-coupled receptors in predicting the prognosis of renal clear cell carcinoma is still unknown. The transcriptome data and clinical profiles of renal clear cell carcinoma patients, were downloaded from TCGA databases, and the validation group data were downloaded from number GSE167573, including 63 tumor samples and 14 normal samples. Single-cell RNA sequencing data were downloaded from the GEO database, No. GSE152938 and selected samples were used for GSEA enrichment analysis, WGCNA subgroup analysis, single-cell data analysis, and mutation analysis to explore the role of G protein-coupled receptor-related genes in the diagnosis and prognosis of renal clear cell carcinoma and to verify their reliability with cellular experiments. Finally, this study establishes a disease model based on G protein-coupled receptor-related genes, which may help to propose targeted therapeutic regimens in different strata of renal cell carcinoma patients.Author names: Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author: Given name [Lisa Jia] Last name [Tran].It's ok!

摘要

G蛋白偶联受体(GPCRs)是一类细胞膜上的受体,通过与G蛋白相互作用来调节细胞内的各种生物学过程,如细胞增殖、分化、迁移、凋亡和代谢。然而,G蛋白偶联受体在预测肾透明细胞癌预后中的作用仍不清楚。从TCGA数据库下载肾透明细胞癌患者的转录组数据和临床资料,从GSE167573下载验证组数据,包括63个肿瘤样本和14个正常样本。从GEO数据库(编号GSE152938)下载单细胞RNA测序数据,并对选定样本进行基因集富集分析(GSEA)、加权基因共表达网络分析(WGCNA)亚组分析、单细胞数据分析和突变分析,以探讨G蛋白偶联受体相关基因在肾透明细胞癌诊断和预后中的作用,并通过细胞实验验证其可靠性。最后,本研究建立了基于G蛋白偶联受体相关基因的疾病模型,这可能有助于为不同分层的肾细胞癌患者提出靶向治疗方案。作者姓名:请确认作者姓名是否准确呈现且顺序正确(名字、中间名/首字母、姓氏)。作者:名字[Lisa Jia] 姓氏[Tran]。没问题!

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/10564696/6116cb396c88/12672_2023_795_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验